XML 37 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Note A - Description of Business and Basis of Presentation (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 23, 2020
Sep. 03, 2019
Feb. 28, 2019
May 31, 2020
Feb. 29, 2020
Oct. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Feb. 29, 2020
Proceeds from Issuance of Long-term Debt, Total                 $ 781  
Revenue from Contract with Customer, Including Assessed Tax             $ 1,925 $ 11,463 $ 10,922 11,463  
Lincoln Park [Member]                      
Sale of Securities, Value, Available to Issue     $ 15,000   $ 4,000           $ 4,000
Purchase Agreement, Term (Month)     3 years   1 year            
Purchase Agreement, Additional Shares to Be Issued as Commitment Shares (in shares)     120,200 308,637 308,637       308,637    
Stock Issued During Period, Shares, New Issues (in shares)                 8,959,545   3,401,271
Proceeds from Issuance of Common Stock                 $ 2,300   $ 5,400
Purchase Agreement, Maximum Shares to be Issued (in shares)       9,268,182              
KVK [Member]                      
License Agreement, Estimated Pre-launch Payments and Costs Reimbursements           $ 3,400          
License Agreement, Pre-launch Payment Reimbursement Within 10 Days of Initial Adoption Milestone           2,000          
License Agreement, Maximum Payments Received for Sales Milestones           $ 53,000          
KVK [Member] | Minimum [Member]                      
License Agreement, Percentage of Net Sales on Rolling Four Quarter Basis Received           30.00%          
KVK [Member] | Maximum [Member]                      
License Agreement, Percentage of Net Sales on Rolling Four Quarter Basis Received           50.00%          
GPC Member | License [Member]                      
Revenue from Contract with Customer, Including Assessed Tax   $ 10,000         $ 0 $ 11,500 $ 7,300 $ 1,000  
Revenue Recognition, Milestone Method, Revenue to be Recognized   63,000                  
Revenue Recognition, Milestone Method, Additional Revenue to be Recognized   420,000                  
Regulatory Milestone Revenue to Be Earned Following FDA Acceptance   $ 5,000   $ 5,000              
Royalty Revenue, Percent   10.00%                  
Paycheck Protection Program CARES Act [Member]                      
Proceeds from Issuance of Long-term Debt, Total $ 800